skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma
Material Type:
Article
Add to My Research

Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma

The oncologist (Dayton, Ohio), 2022-09, Vol.27 (9), p.e703-e722 [Peer Reviewed Journal]

Published by Oxford University Press 2022. ;COPYRIGHT 2022 Oxford University Press ;Published by Oxford University Press 2022. 2022 The data published online to support this summary are the property of the authors. Please contact the authors about reuse rights of the original data. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac099 ;PMID: 35671201

Full text available

2
A Phase Ib Study of Safety and Pharmacokinetics of Ramucirumab in Combination With Paclitaxel in Patients With Advanced Gastric Adenocarcinomas
Material Type:
Article
Add to My Research

A Phase Ib Study of Safety and Pharmacokinetics of Ramucirumab in Combination With Paclitaxel in Patients With Advanced Gastric Adenocarcinomas

The oncologist (Dayton, Ohio), 2015-05, Vol.20 (5), p.493-494 [Peer Reviewed Journal]

2015 AlphaMed Press ;AlphaMed Press; the data published online to support this summary is the property of the authors. ;AlphaMed Press; the data published online to support this summary is the property of the authors. 2015 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2014-0440 ;PMID: 25888272

Full text available

3
Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy
Material Type:
Article
Add to My Research

Multicenter Retrospective Study of 132 Patients with Unresectable Small Bowel Adenocarcinoma Treated with Chemotherapy

The oncologist (Dayton, Ohio), 2012-09, Vol.17 (9), p.1163-1170 [Peer Reviewed Journal]

2012 AlphaMed Press ;AlphaMed Press 2012 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2012-0079 ;PMID: 22622149

Full text available

4
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer
Material Type:
Article
Add to My Research

aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer

The oncologist (Dayton, Ohio), 2019-03, Vol.24 (3), p.327-337 [Peer Reviewed Journal]

AlphaMed Press 2018 ;AlphaMed Press 2018. ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2018-0119 ;PMID: 30425180

Full text available

Searching Remote Databases, Please Wait